_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
The rates for over 400 procedures were revised
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
The company plans to submit the IND application by the end of 2021
This one-of-a-kind innovation challenge is aimed at addressing the challenges faced by healthcare providers in digital technology adoption
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
This project will be conducted at the “NURA,” a health screening centre that Fujifilm opened in India in February this year
CuraTeQ Biologics is on track for filing a second oncology biosimilar
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan
Subscribe To Our Newsletter & Stay Updated
